Peripheral clinic versus centralized laboratory-based Xpert MTB/RIF performance: Experience gained from a pragmatic, stepped-wedge trial in Botswana

Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings

(2015) Rishi K. Gupta et al.   AIDS

Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries

(2014) Jacob Creswell et al.   BMC INFECTIOUS DISEASES

Feasibility of Decentralised Deployment of Xpert MTB/RIF Test at Lower Level of Health System in India

(2014) Neeraj Raizada et al.   PLoS One

Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial

(2013) Grant Theron et al.   LANCET

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

(2011) Catharina C Boehme et al.   LANCET

Rapid and Accurate Detection of Mycobacterium tuberculosis in Sputum Samples by Cepheid Xpert MTB/RIF Assay—A Clinical Validation Study

(2011) Andrea Rachow et al.   PLoS One

Xpert®MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope?

(2010) Annelies Van Rie et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Containment of Bioaerosol Infection Risk by the Xpert MTB/RIF Assay and Its Applicability to Point-of-Care Settings

(2010) P. P. Banada et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Rapid Molecular Detection of Tuberculosis and Rifampin Resistance

(2010) Catharina C. Boehme et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rapid Detection ofMycobacterium tuberculosisand Rifampin Resistance by Use of On-Demand, Near-Patient Technology

(2009) Danica Helb et al.   JOURNAL OF CLINICAL MICROBIOLOGY